ABEONA THERAPEUTICS INC. 8-K

What Happened
Abeona Therapeutics Inc. filed an 8-K (Item 5.02) reporting that Michael Amoroso resigned as a member of the company's Board of Directors effective June 11, 2026. In connection with his board resignation, Mr. Amoroso also stepped down from the Board’s Nominating and Corporate Governance Committee. The filing states his resignation was for personal reasons and not due to any disagreement with the company on its operations, policies or practices.

Key Details

• Resignation date: effective immediately on June 11, 2026.
• Positions vacated: member of the Board of Directors and member of the Nominating and Corporate Governance Committee.
• Reason given: personal reasons; explicitly not due to any disagreement with the company.
• Filing: reported in an 8-K under Item 5.02; the filing did not announce a replacement or changes to other committees.

Why It Matters
Board departures can affect corporate governance and investor oversight. This filing indicates no dispute with management, and the company has not reported a replacement yet. Investors should note the change in board composition and watch for any future filings announcing a new director or committee reassignments, which could alter governance dynamics.